TauRx Therapeutics Ltd   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Singapore Singapore (2002)

Organization Overview

First Clinical Trial
2004
NCT00515333
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

TauRx Therapeutics Ltd

Active Ingredients

Drugs in Phase 3 Trials (1)

trx0237 (7 trials)

Drugs in Phase 2 Trials (1)

trx0014 (2 trials)

Drugs in Phase 1 Trials (1)

trx0037 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 3)

Aphasia, Primary Progressive (Phase 3)

Dementia (Phase 3)

Frontotemporal Dementia (Phase 3)

Pick Disease of the Brain (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 11
  • # of Trial APIs: 3